These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 39180753
1. Retinol dehydrogenase 10 promotes epithelial-mesenchymal transition in spinal cord gliomas via PI3K/AKT pathway. Zhao Z, Song Z, Wang Z, Zhang F, Ding Z, Zhao Z, Liu L, Fan T. Int J Immunopathol Pharmacol; 2024; 38():3946320241276336. PubMed ID: 39180753 [Abstract] [Full Text] [Related]
2. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. Chi M, Liu J, Mei C, Shi Y, Liu N, Jiang X, Liu C, Xue N, Hong H, Xie J, Sun X, Yin B, Meng X, Wang B. J Exp Clin Cancer Res; 2022 May 17; 41(1):175. PubMed ID: 35581606 [Abstract] [Full Text] [Related]
3. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter. Zhang J, Yang Y, Dong Y, Liu C. Int J Mol Med; 2022 Feb 17; 49(2):. PubMed ID: 34913078 [Abstract] [Full Text] [Related]
4. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition. Zhong C, Li X, Tao B, Peng L, Peng T, Yang X, Xia X, Chen L. Biomed Pharmacother; 2019 Aug 17; 116():109013. PubMed ID: 31146105 [Abstract] [Full Text] [Related]
5. NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation. Zhang A, Peng S, Sun S, Ye S, Zhao Y, Wu Q. Cancer Med; 2024 Aug 17; 13(16):e70100. PubMed ID: 39149873 [Abstract] [Full Text] [Related]
6. Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression. Liang Z, Ge Y, Li J, Bai Y, Xiao Z, Yan R, An G, Zhang D. J Cancer Res Clin Oncol; 2024 Jul 09; 150(7):342. PubMed ID: 38980538 [Abstract] [Full Text] [Related]
7. miR-451 suppresses EMT and metastasis in glioma cells. Nan Y, Guo L, Lu Y, Guo G, Hong R, Zhao L, Wang L, Ren B, Yu K, Zhong Y, Huang Q. Cell Cycle; 2021 Jul 09; 20(13):1270-1278. PubMed ID: 34048322 [Abstract] [Full Text] [Related]
8. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans. Zhang L, Zhang W, Li Y, Alvarez A, Li Z, Wang Y, Song L, Lv D, Nakano I, Hu B, Cheng SY, Feng H. Oncogene; 2016 Oct 27; 35(43):5641-5652. PubMed ID: 27041571 [Abstract] [Full Text] [Related]
9. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway. Chen H, Zhu D, Zheng Z, Cai Y, Chen Z, Xie W. Clin Transl Oncol; 2019 Jul 27; 21(7):939-949. PubMed ID: 30607788 [Abstract] [Full Text] [Related]
10. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway. Gao X, Jiang W, Ke Z, Huang Q, Chen L, Zhang G, Li C, Yu X. Biochem Biophys Res Commun; 2022 Jan 01; 586():34-41. PubMed ID: 34826698 [Abstract] [Full Text] [Related]
11. Hsa_circ_0030586 promotes epithelial-mesenchymal transition in prostate cancer via PI3K-AKT signaling. Luo GC, Chen L, Fang J, Yan ZJ. Bioengineered; 2021 Dec 01; 12(2):11089-11107. PubMed ID: 34852706 [Abstract] [Full Text] [Related]
12. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C, Shan Z, Hong J, Yang L. Int J Oncol; 2017 Jul 01; 51(1):235-244. PubMed ID: 28534966 [Abstract] [Full Text] [Related]
13. Retinol dehydrogenase 10 promotes metastasis of glioma cells via the transforming growth factor-β/SMAD signaling pathway. Guan F, Kang Z, Wang L, Wang K, Mao BB, Peng WC, Zhang BL, Lin ZY, Zhang JT, Hu ZQ. Chin Med J (Engl); 2019 Oct 20; 132(20):2430-2437. PubMed ID: 31613821 [Abstract] [Full Text] [Related]
14. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells. Yang MH, Jung SH, Um JY, Kumar AP, Sethi G, Ahn KS. Life Sci; 2022 Apr 15; 295():120395. PubMed ID: 35181309 [Abstract] [Full Text] [Related]
15. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway. Sun J, Zhao X, Jiang H, Yang T, Li D, Yang X, Jia A, Ma Y, Qian Z. Tissue Cell; 2022 Aug 15; 77():101817. PubMed ID: 35679685 [Abstract] [Full Text] [Related]
16. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J, Zhang XT, Liu XL, Fan L, Li C, Sun Y, Liang XH, Wang JB, Mei QB, Zhang F, Zhang T. Cell Signal; 2016 Nov 15; 28(11):1673-82. PubMed ID: 27449264 [Abstract] [Full Text] [Related]
17. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway. Wei N, Wu X, Yu Y, Zhou H, Cui K, Zhao X, Zhang X. Front Biosci (Landmark Ed); 2024 Apr 08; 29(4):140. PubMed ID: 38682195 [Abstract] [Full Text] [Related]
18. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. Song SZ, Lin S, Liu JN, Zhang MB, Du YT, Zhang DD, Xu WH, Wang HB. J Cell Physiol; 2019 Aug 08; 234(10):18587-18601. PubMed ID: 30953349 [Abstract] [Full Text] [Related]
19. TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway. Gao F, Liu S, Wang J, Wei G, Yu C, Zheng L, Sun L, Wang G, Sun Y, Bao Y, Song Z. J Exp Clin Cancer Res; 2024 Jul 20; 43(1):201. PubMed ID: 39030572 [Abstract] [Full Text] [Related]
20. KIF3C Promotes Proliferation, Migration, and Invasion of Glioma Cells by Activating the PI3K/AKT Pathway and Inducing EMT. Gao Y, Zheng H, Li L, Zhou C, Chen X, Zhou X, Cao Y. Biomed Res Int; 2020 Jul 20; 2020():6349312. PubMed ID: 33150178 [Abstract] [Full Text] [Related] Page: [Next] [New Search]